Liver Disease Clinical Trials

Showing 161-180 of 1,279 trials

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

NCT06218589

This study aims to test the utility of Velacur ultrasound as a non-invasive, rapid, point of care diagnostic tool for detecting the presence and amount of hepatic steatosis in children and adolescents aged 2 - 20 years.

Metabolic Dysfunction Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver Disease (NAFLD)

Emory University200 participantsStarted Jan 2024

Atlanta, Georgia, United States • Atlanta, Georgia, United States

RECRUITINGPhase 2/3

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

NCT06007846

This is a single-site prospective study to describe efficacy endpoints of single agent memantine in patients with unresectable, locally advanced, or metastatic HCC otherwise not deemed candidates for intensive systemic therapy. In addition to the primary endpoint and multiple secondary efficacy endpoints, we will describe changes in quality of life on treatment over time.

Hepatocellular CarcinomaCirrhosis

Inova Health Care Services12 participantsStarted Jul 2023

Fairfax, Virginia, United States • Falls Church, Virginia, United States

Non-Invasive Diagnostic Tests for MASLD in Pediatric Population

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

Related Searches

Study to Evaluate the Effectiveness of Legalon®

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Measuring Patient Reported Needs in Outpatient Liver Disease Management

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC

French Cohort for the Study of Non-invasive Tests of Liver Lesions in NAFLD/NASH (FreSH Cohort)

Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer

CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use

Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease

TIPS in Patients With Decompensated Liver Cirrhosis

Study of the Impact of HYPOglycaemia on Sarcopenia in CIRrhosis

Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients

Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers

Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients

Genetic Collection Protocol

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis

ELECTRICAL STIMULATION AND EXERCISE FOR MUSCLE LOSS IN CIRRHOSIS PATIENTS